Have a personal or library account? Click to login
Severe hyperprolactinemia during lurasidone treatment in a 16-year old girl with schizophrenia – a case report Cover

Severe hyperprolactinemia during lurasidone treatment in a 16-year old girl with schizophrenia – a case report

Open Access
|Jul 2022

Abstract

Background

Increase of serum prolactin is a common adverse effect to antipsychotic medication, potentially leading to galactorrhea, menstrual cycle disturbances or sexual adverse effects. Lurasidone is commonly associated with a low risk of prolactin change.

Objective

To describe a case of severe hyperprolactinemia in a 16-year old female with schizophrenia.

Method

Case report.

Results

We saw a severe and sustained prolactin increase during treatment with lurasidone.

Conclusions

Although lurasidone is usually considered not to increase prolactin, some patients may experience this adverse effect. As related subjective consequences may be falsely attributed to the disease or as direct effects of the antipsycotic agent, serum prolactin measurements should be made prior to and during antipsychotic treatment regardless of medication choice.

Language: English
Page range: 87 - 88
Published on: Jul 3, 2022
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Karsten Gjessing Jensen, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.